These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16411113)

  • 1. What is the impact of resistance to activated protein C (Leiden mutation to factor V) in inflammatory bowel disease?
    Attvall E; Frigyesi A; Sternby B
    Int J Colorectal Dis; 2006 Oct; 21(7):705-10. PubMed ID: 16411113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to activated protein C and low levels of free protein S in Greek patients with inflammatory bowel disease.
    Koutroubakis IE; Sfiridaki A; Mouzas IA; Maladaki A; Kapsoritakis A; Roussomoustakaki M; Kouroumalis EA; Manousos ON
    Am J Gastroenterol; 2000 Jan; 95(1):190-4. PubMed ID: 10638581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor V Leiden mutation is not increased in patients with inflammatory bowel disease.
    Zauber NP; Sabbath-Solitare M; Rajoria G; Mogan G
    J Clin Gastroenterol; 1998 Oct; 27(3):215-6. PubMed ID: 9802448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of hyperhomocysteinaemia, activated protein C resistance and prothrombin gene mutation in inflammatory bowel disease.
    Mahmood A; Needham J; Prosser J; Mainwaring J; Trebble T; Mahy G; Ramage J
    Eur J Gastroenterol Hepatol; 2005 Jul; 17(7):739-44. PubMed ID: 15947551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to activated protein C is a risk factor for fibrostenosis in Crohn's disease.
    Novacek G; Miehsler W; Palkovits J; Reinisch W; Waldhör T; Kapiotis S; Gangl A; Vogelsang H
    World J Gastroenterol; 2006 Oct; 12(37):6026-31. PubMed ID: 17009403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to activated protein C--frequent etiologic factor for venous thrombosis.
    Simkova M; Simko F; Kovacs L
    Bratisl Lek Listy; 2001; 102(5):240-7. PubMed ID: 11725376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and risk factors for venous thromboembolic complications in the Swiss Inflammatory Bowel Disease Cohort.
    Alatri A; Schoepfer A; Fournier N; Engelberger RP; Safroneeva E; Vavricka S; Biedermann L; Calanca L; Mazzolai L;
    Scand J Gastroenterol; 2016 Oct; 51(10):1200-5. PubMed ID: 27211077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fistulizing pattern in Crohn's disease and pancolitis in ulcerative colitis are independent risk factors for cancer: a single-center cohort study.
    Biancone L; Zuzzi S; Ranieri M; Petruzziello C; Calabrese E; Onali S; Ascolani M; Zorzi F; Condino G; Iacobelli S; Pallone F
    J Crohns Colitis; 2012 Jun; 6(5):578-87. PubMed ID: 22398047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombosis in inflammatory bowel diseases: role of inherited thrombophilia.
    Spina L; Saibeni S; Battaglioli T; Peyvandi F; de Franchis R; Vecchi M
    Am J Gastroenterol; 2005 Sep; 100(9):2036-41. PubMed ID: 16128949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombosis in inflammatory bowel disease: clinical setting, procoagulant profile and factor V Leiden.
    Jackson LM; O'Gorman PJ; O'Connell J; Cronin CC; Cotter KP; Shanahan F
    QJM; 1997 Mar; 90(3):183-8. PubMed ID: 9093595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An investigation of the association of the factor V Leiden mutation and inflammatory bowel disease.
    Haslam N; Standen GR; Probert CS
    Eur J Gastroenterol Hepatol; 1999 Nov; 11(11):1289-91. PubMed ID: 10563542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease (IBD) in Germany: an online IBD registry.
    Bokemeyer B; Hardt J; Hüppe D; Prenzler A; Conrad S; Düffelmeyer M; Hartmann P; Hoffstadt M; Klugmann T; Schmidt C; Weismüller J; Mittendorf T; Raspe H
    J Crohns Colitis; 2013 Jun; 7(5):355-68. PubMed ID: 22503168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of hypercoagulable disorders in inflammatory bowel disease.
    Kohoutova D; Pecka M; Cihak M; Cyrany J; Maly J; Bures J
    Scand J Gastroenterol; 2014 Mar; 49(3):287-94. PubMed ID: 24328909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of activated protein C resistance (Factor V Leiden) in Lagos, Nigeria.
    Adeyemo TA; Adediran A; Akinbami AA; Akanmu AS
    Niger J Clin Pract; 2012; 15(2):136-41. PubMed ID: 22718159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crohn's-like clinical and pathological manifestations of giant inflammatory polyposis in IBD: a potential diagnostic pitfall.
    Naymagon S; Mikulasovich M; Gui X; Ullman TA; Harpaz N
    J Crohns Colitis; 2014 Jul; 8(7):635-40. PubMed ID: 24368253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer complicating inflammatory bowel disease: similarities and differences between Crohn's and ulcerative colitis based on three decades of experience.
    Kiran RP; Khoury W; Church JM; Lavery IC; Fazio VW; Remzi FH
    Ann Surg; 2010 Aug; 252(2):330-5. PubMed ID: 20622662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients.
    Simian D; Fluxá D; Flores L; Lubascher J; Ibáñez P; Figueroa C; Kronberg U; Acuña R; Moreno M; Quera R
    World J Gastroenterol; 2016 Jun; 22(22):5267-75. PubMed ID: 27298570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients.
    Yasa MH; Bolaman Z; Yukselen V; Kadikoylu G; Karaoglul AO; Batun S
    Hepatogastroenterology; 2007; 54(77):1438-42. PubMed ID: 17708272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated protein C resistance and factor V Leiden in Mexico.
    Majluf-Cruz A; Moreno-Hernández M; Ruiz-de-Chávez-Ochoa A; Monroy-García R; Majluf-Cruz K; Guardado-Mendoza R; Molina-Avila I; Isordia-Salas I; Corona-de la Peña N; Vargas-Vorackova F; Vela-Ojeda J; García-Chávez J
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):428-37. PubMed ID: 18160617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.